Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.00739795918367345 -0.011734693877551 -0.00535714285714288 -0.000255102040816457
Stock impact report

GSK Gets Full Control of Sensodyne Maker for $13 Billion [Bloomberg Business News]

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
The new bosses of two of Europe’s largest drugmakers are pivoting in different directions, with GlaxoSmithKline Plc doubling down on consumer health as Novartis AG focuses on finding new prescription medicines. Glaxo Chief Executive Officer Emma Walmsley’s $13 billion deal for Novartis’s stake in a joint venture that includes Panadol pain relievers and Theraflu cold medicine comes only days after the U.K. company abandoned its pursuit of Pfizer Inc. ’s consumer unit. The deal gives Novartis’s Vas Narasimhan more firepower for the Swiss giant’s drug business and acquisitions. Emma Walmsley Source: GlaxoSmithKline Plc Narasimhan, who rose to the top spot last month, has said the over-the-counter business is no longer central to the strategy as he focuses on breakthroughs for cancer and other diseases. Walmsley, who took over last year, has emphasized the benefit of combining the more steadily performing consumer and vaccine businesses under the sam Show less Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GSK alerts
Opt-in for
GSK alerts

from News Quantified
Opt-in for
GSK alerts

from News Quantified